e-learning
resources
Madrid 2019
Monday, 30.09.2019
Advances in COPD pharmacology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Pigment epithelium-derived factor regulates cigarette-induced abnormal apoptosis of alveolar type II cells
L. Dai (Chengdu, Sichuan, China), T. Wang (Chengdu, Sichuan, China), L. Liu (Chengdu, Sichuan, China), J. Chen (Chengdu, Sichuan, China), F. Wen (Chengdu, Sichuan, China)
Source:
International Congress 2019 – Advances in COPD pharmacology
Session:
Advances in COPD pharmacology
Session type:
Poster Discussion
Number:
2029
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Dai (Chengdu, Sichuan, China), T. Wang (Chengdu, Sichuan, China), L. Liu (Chengdu, Sichuan, China), J. Chen (Chengdu, Sichuan, China), F. Wen (Chengdu, Sichuan, China). Late Breaking Abstract - Pigment epithelium-derived factor regulates cigarette-induced abnormal apoptosis of alveolar type II cells. 2029
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Late Breaking Abstract - WNT/ß-catenin signaling induces cellular senescence in lung alveolar epithelial cells
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019
Late Breaking Abstract - Loss of PTEN induces alveolar epithelial cell senescence resulting in lung fibrosis via activated NF-?B
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
Late Breaking Abstract - Aging impairs alveolar epithelial type II cell function in acute lung injury
Source: International Congress 2019 – Cellular metabolism and immune senescence in lung pathology
Year: 2019
Late Breaking Abstract - Caveolin-1 derived peptide LTI-03 promotes epithelial cell survival and attenuates pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Late Breaking Abstract - DCLK1 mediates thrombin-induced IL-8/CXCL8 expression in lung epithelial cells
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021
Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008
Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts
in vitro
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Late Breaking Abstract - The role of the transcription factor PU.1 in lung cancer
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Late Breaking Abstract - Transcriptional response to RSV in asthma primary bronchial epithelial cells: are the basal cells responsible for the reduced NF-kB response?
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Late Breaking Abstract - Role of ß-catenin and Notch signalling in increased airway mucous cell differentiation in asthma
Source: International Congress 2019 – Molecular and experimental paediatric lung disease
Year: 2019
Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development
Source: International Congress 2017 – Postnatal lung growth and development
Year: 2017
Ex vivo
trans-differentiation of primary human alveolar epithelial cells type II by TGFb
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Late Breaking Abstract - TGF-ß impairs fibroblast ability to support lung organoid formation: pharmacological restoration by GSK-3 inhibition and secreted niche factor supplementation
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018
TGF-β receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung
Source: Eur Respir J 2008; 32: 285-295
Year: 2008
Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro
Source: Eur Respir J 2002; 20: 1449-1456
Year: 2002
Regulation of human adult primary alveolar type II cell surfactant protein production by epithelial growth factors and pro-inflammatory cytokines
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Late Breaking Abstract - Effect of Hypercapnia in human primary culture of alveolar cells in vitro
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018
Late Breaking Abstract - Membrane bile acid receptor contributes to the proliferation of lung cancer cells induced by lung fibroblast-tumor cells interaction though TLR4/NF-kB signaling pathway
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Rac-specific nucleotide exchange factor Asef mediates lung endothelial barrier protection by hepatocyte growth factor
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept